Passage Bio, Inc.

PASG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 May 21, 2026
10-Q May 12, 2026 10-Q
8-K Apr 28, 2026 FORM 8-K
8-K Apr 20, 2026 FORM 8-K
ARS Apr 7, 2026 ARS
DEFA14A Apr 7, 2026 DEFA14A
DEF 14A Apr 7, 2026 DEF 14A
4 Mar 18, 2026
4 Mar 18, 2026
8-K Mar 10, 2026 FORM 8-K
S-8 Mar 4, 2026 FORM S-8
10-K Mar 3, 2026 10-K
8-K Mar 3, 2026 8-K
4 Jan 12, 2026
4 Jan 12, 2026
8-K Jan 12, 2026 FORM 8-K
144 Jan 9, 2026
4 Dec 29, 2025
4 Dec 29, 2025
SCHEDULE 13G/A Nov 14, 2025
10-Q Nov 10, 2025 10-Q
8-K Nov 10, 2025 8-K
8-K Sep 18, 2025 FORM 8-K
4 Sep 15, 2025
10-Q Aug 12, 2025 10-Q
← Newer Page 2 of 18 · 442 filings Older →